You are on page 1of 1

Patient Name : TUSHAR Lab No.

: KKD2106115325
Age / Sex : 19 Y/M
20 Y Registration On : 01-06-2021
05-04-22
Referred By : Dr.SELF Collection Date : 01/Jun/2021
05/04/2022 09:22AM
Patient ID : UKKD.0000069224 Received Date : 01/Jun/2021
05/04/2022 10:44AM
Centre : HARGOVIND ENCLAVE Approved Date : 05/04/2022 01:24PM
01/Jun/2021

Test Name Result Biological Ref. Interval Method

Liver Function Test , Serum


Total Protein 7.9 g/dL 6.5-8.2 Biuret, No Serum Blank
Albumin 5.0 g/dL 4.6 - 5.3 Bromocresol Green
Globulin 2.9 gm/dL 2.0-3.5 Calculated
A/G Ratio 1.72 Ratio 1.5-2.5 Calculated
Total Bilirubin 1.12 mg/dL 0.2-1.3 Azobilirubin/dyphylline
Conjugated Bilirubin 0.41 mg/dL <0.3 Calculated
Unconjugated Bilirubin 0.71 mg/dL <1.1 Spectrophotometry
SGOT (AST) 73 U/L 18-54 Enzymatic Colorimetric
SGPT (ALT) 169 U/L 4-50 UV with P5P
SGOT/SGPT Ratio 0.43 Ratio Calculated
Alkaline Phosphatase 123 U/L 56 - 167 PNPP, AMP buffer
Gamma Glutamyl Transferase 66 U/L 10 - 33 G-glutamyl-p-nitroanilide

-----------------------------------------------------------------------------------------------------------------
The laboratory is NABL Accredited for tests in LFT
-----------------------------------------------------------------------------------------------------------------
Technology: Dry Chemistry (VITROS MicroSlide, MicroSensor and Intellicheck Technology)
---------------------------------------------------------------------------------------------------------------------
Sample Type: Serum
Analyzer: Fully Automated Biochemistry and ImmunoAssay Analyzer: VITROS 5600
---------------------------------------------------------------------------------------------------------------------
Clinical Significance of LFT: The clinical suspicion of liver disease usually leads to the measurement of the liver function tests (LFT) which include measurement of several enzymes, serum bilirubin and albumin. These parameters may
point to an underlying pathological process and direct further investigation. The aim of investigation in patients with suspected liver disease are:
ꞏ To detect hepatic abnormality ꞏ Measurement of severity of liver damage ꞏ Identify the specific cause
ꞏ Investigate possible complications
---------------------------------------------------------------------------------------------------------------------
Remarks: Please correlate clinically.
---------------------------------------------------------------------------------------------------------------------

*** End Of Report ***

Scan to Validate Report Page 1 of 4

SIN No:CL00329279

House Of Diagnostics Healthcare Pvt. Ltd., 15 and 16 Hargovind Enclave, Delhi - 110092

You might also like